- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07646782
Human Observatory Study (HOS)
The Human Observatory: A Prospective Individual and Population-Level Study of Aging, Health, and Longevity
Aperçu de l'étude
Statut
Les conditions
- Maladies cardiovasculaires
- Tumeurs
- Mortalité
- Maladies professionnelles
- Dysfonctionnement cognitif
- Syndrome métabolique
- Démence
- Fragilité
- Vieillissement
- Handicap physique
- Maladie musculo-squelettique
- Activités de la vie quotidienne
- Exposition environnementale
- Déterminants sociaux de la santé
- Maladie neurodégénérative
- Qualité de vie liée à la santé
- Équité en santé
- Mortalité toutes causes confondues
- Life Expectancy
Intervention / Traitement
Description détaillée
Existing approaches to human health prediction face a structural limitation: individual clinical studies measure biology without capturing the environment, while population epidemiology captures the environment without individual biological ground truth. The Human Observatory Study resolves this by operating at both levels simultaneously through a linked dual-layer architecture.
At the individual level, participants enrolled in the 100-Year Human Aging Study contribute comprehensive multi-system health measurements. This includes clinical, physiological, cognitive, behavioral, social, occupational, and environmental data collected at fixed and mobile clinical sites. These measurements provide the biological present timepoint that historical population data alone cannot supply.
At the population level, the Observatory continuously ingests ecological data from public and private registries across multiple input domains. This includes air quality, water and chemical contaminants, wildfire and smoke exposure, altitude and terrain, climate, satellite earth observation, occupational and industrial exposure, mortality and vital statistics, demographics and social determinants, and clinical data networks at geographic resolutions from home address to global scale and beyond. This ecological layer captures the environmental and social causal structure of health and disease continuously and does not require individual enrollment.
A foundational input domain is genealogy and family history. Health and disease run in families across generations. The Observatory is designed to build and continuously expand a linked genealogical database connecting living and historical individuals to their family health histories. Information is obtained from public genealogical records, death registries, family history self-report, and genetic data where available. The long-term vision is a genealogical infrastructure of sufficient depth and breadth to trace familial health patterns across the full recorded human family tree. Therefore connecting individual present-timepoint biology to multigenerational patterns of disease, longevity, and environmental exposure that no existing biobank or longitudinal study has attempted to capture at this scale.
The linked architecture enables a feedback loop with two outputs: population-level causal estimates that inform individual screening recommendations, and individual clinical data that give population models a present biological anchor for prospective forecasting. The degree to which each input domain, alone and in combination, predicts health, disease, and death across geographic scales from neighborhood to global and beyond is the central scientific question the Observatory is designed to answer.
The Observatory launches in Colorado, chosen as the founding site for its exceptional natural variation in altitude, wildfire smoke corridors, mining and industrial chemical geographies, and frontier-to-urban socioeconomic gradient all within a compact, well-characterized geography with established academic research infrastructure. Colorado proves the model. The architecture then replicates geographically, with each new location enriching the world model for every other. The long-term vision is global coverage and beyond. Every geography will contribute its environmental, social, and biological signal to a world model that gets more accurate with every geography studied, every participant enrolled, every dataset ingested, and every causal analysis conducted.
The Human Observatory Study is conducted across all Longevity Metrics participation pathways, current and future: the Boulder fixed laboratory; all current and future fixed clinical sites; mobile screening units including the Health Ahead Bus; and an online participation pathway through which participants enroll and contribute structured data without in-person screening. Ecological data are ingested continuously from public and private registries independent of individual enrollment. All pathways operate under a single protocol with identical procedures, data management, informed consent, and safety standards.
This study is one of four that compound into one system. The 100-Year Human Aging Study (NCT07563777) supplies the clinical data and validates what it means for health, disease, disability, and death. The Health Ahead Comparative Effectiveness Study (NCT07669168) moves the screening toward increasing automation and mobility while maintaining quality. The Longevity Metrics AI/ML Development Study (NCT pending approval) builds the models that make automation, prediction, and broad utilization possible, and returns each model's geographic residuals here. This study does with sociodemographic and environmental data what the 100-Year study does with clinical data, and defines the validated envelope within which each model's output is labeled.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: William Brandenburg, MD
- Numéro de téléphone: 13035010016
- E-mail: info@longevitymetrics.org
Lieux d'étude
-
-
Colorado
-
Boulder, Colorado, États-Unis, 80301
- Recrutement
- Longevity Metrics
-
Contact:
- William Brandenburg, MD
- Numéro de téléphone: 3035010016
- E-mail: info@longevitymetrics.org
-
Contact:
- E-mail: info@longevitymetrics.org
-
Chercheur principal:
- William Brandenburg, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Enrolled in the 100-Year Human Aging Study at any fixed or mobile clinical site; OR completion of online health screener with provision of geographic anchor data and consent.
Exclusion Criteria:
- Age under 18 years (current protocol; pediatric amendment planned).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Life Expectancy Estimates by Geography
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Continuously-updated life expectancy point estimates with credible intervals generated at individual, neighborhood, ZIP code, county, state, national, global, and beyond-earth scales using individual clinical data linked to population mortality records, environmental context, and ecological data.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Geographic Disease Cluster and Outbreak Detection
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Statistically anomalous concentrations of incident disease, mortality spikes, or shared symptom patterns at neighborhood and community resolution.
|
From enrollment until death, assessed periodically, up to 100 years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Individual Screening Recommendation Accuracy
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Concordance between population-level causal estimates used to generate individualized screening recommendations and actual individual health outcomes at longitudinal follow-up, assessed periodically as outcomes accrue.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Causal Effect Estimates for Modifiable Exposures
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Estimated attributable life-years gained or lost per unit change in modifiable environmental, occupational, and social exposures.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Geographic Variation in Disability-Free Life Expectancy
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Disability-free life expectancy stratified by geography, ascertained via the functional independence and disability survey instrument used across all three associated protocols.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Health Equity Characterization
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Life expectancy gaps and chronic disease disparities stratified by geography, income, race and ethnicity, educational attainment, and rural-urban classification.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Human Tree of Life Growth
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Total participants linked to genealogical record; multigenerational depth achieved; proportion of enrolled participants with identified biological relatives in the registry; total historical individuals linked across all genealogical databases.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Population Biological Age Acceleration
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Mean difference between chronological age and biological age estimate for repeat-visit participants, stratified by geographic and demographic characteristics.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Multi-Domain Predictor Modeling
Délai: From enrollment until death, assessed periodically, up to 100 years
|
Assessment of individual and composite clinical, biological, behavioral, environmental, social, occupational, genealogical, and geographic measurements as predictors of all-cause mortality, life expectancy, and incident serious disease at population scale; analyses evaluate which domains are independently predictive, which are redundant, and which combinations provide additive or synergistic predictive value.
|
From enrollment until death, assessed periodically, up to 100 years
|
|
Incident Serious Health Events and Chronic Disease
Délai: From enrollment until death, assessed periodically, up to 100 years
|
New diagnosis of myocardial infarction, stroke, cancer, dementia, heart failure, atrial fibrillation, sepsis, venous thromboembolism, COPD, chronic hypoxia, major fracture, type 2 diabetes, hypertension, chronic kidney disease, metabolic syndrome, or osteoporosis ascertained via periodic follow-up contact and health data network linkage.
|
From enrollment until death, assessed periodically, up to 100 years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: William Brandenburg, MD, Longevity Metrics
Publications et liens utiles
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
- La composition corporelle
- Santé de la population
- Équité en santé
- Médecine préventive
- Histoire de famille
- longévité
- Déterminants sociaux
- espérance de vie
- Déclin fonctionnel
- vieillissement biologique
- Durée de vie
- Test d'effort cardiopulmonaire
- Généalogie
- exposome
- inférence causale
- Santé environnementale
- Prédiction de mortalité
- Biomarker Validation
- Centenarian
- Human Family Tree
- Neighborhood Health
- Geographic Health Disparities
- Space Medicine
- Aerospace Medicine
- World Model
Termes MeSH pertinents supplémentaires
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Les troubles mentaux
- Processus pathologiques
- Maladies métaboliques
- Troubles neurocognitifs
- Troubles du métabolisme du glucose
- Troubles cognitifs
- Résistance à l'insuline
- Hyperinsulinisme
- Conditions pathologiques, signes et symptômes
- Maladies nutritionnelles et métaboliques
- Fragilité
- Tumeurs
- Dysfonctionnement cognitif
- Maladies cardiovasculaires
- Syndrome métabolique
- Maladies musculo-squelettiques
- Démence
- Maladies neurodégénératives
- Maladies professionnelles
Autres numéros d'identification d'étude
- Observatory
- IORG0012336; IRB00014601 (Autre identifiant: OHRP)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .